Notice2024-30620
Agency Information Collection Activities: Proposed Collection; Comment Request
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 23, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Medicare & Medicaid Services
Abstract
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 246 (Monday, December 23, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Pages 104545-104546]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-30620]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers: CMS-10630 and CMS-10798]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), Federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and
[[Page 104546]]
clarity of the information to be collected, and the use of automated
collection techniques or other forms of information technology to
minimize the information collection burden.
DATES: Comments must be received by February 21, 2025.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
<a href="http://www.regulations.gov">http://www.regulations.gov</a>. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number: ___, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: <a href="https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing">https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing</a>.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10630 The PACE Organization (PO) Monitoring and Audit Process
CMS-10798 Application for Part B Immunosuppressive Drug Coverage (Part
B-ID)
Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
Information Collections
1. Type of Information Collection Request: Revision of a currently
approved information collection; Title of Information Collection: The
PACE Organization (PO) Monitoring and Audit Process; Use: Sections
1894(e)(4) and 1934(e)(4) of the Act and the implementing regulations
at 42 CFR 460.190 and 460.192 mandate that CMS, in conjunction with the
SAA, audit POs annually for the first 3 years (during the trial
period), and then on an ongoing basis following the trial period. The
information gathered during this audit will be used by the Medicare
Parts C and D Oversight and Enforcement Group (MOEG) within the Center
for Medicare (CM), as well as the SAA, to assess POs' compliance with
PACE program requirements. If outliers or other data anomalies are
detected, other offices within CMS will work in collaboration with MOEG
for follow-up and resolution. Additionally, POs will receive the audit
results and will be required to implement corrective action to correct
any identified deficiencies.
Information collected from the POs for use in the audit is obtained
electronically through the Health Plan Management System (HPMS). HPMS
is a system that was developed and is maintained by CMS and is used to
securely transmit information between CMS and POs. All POs have access
to HPMS, and users create and maintain a secure user id and password
that is used each time HPMS is accessed. Form Number: CMS-10630 (OMB
control number: 0938-1327); Frequency: Annually; Affected Public:
Private Sector, State, Local, or Tribal Governments, Business or other
for-profits, Not-for-profits institutions; Number of Respondents: 40;
Total Annual Responses: 43; Total Annual Hours: 31,200. (For policy
questions regarding this collection contact Katrina Hoadley at 410-786-
8480 or <a href="/cdn-cgi/l/email-protection#dcb7bda8aeb5b2bdf2b4b3bdb8b0b9a59cbfb1aff2b4b4aff2bbb3aa"><span class="__cf_email__" data-cfemail="f19a908583989f90df999e90959d9488b1929c82df999982df969e87">[email protected]</span></a>).
2. Type of Information Collection Request: Revision of a currently
approved information collection; Title: Application for Part B
Immunosuppressive Drug Coverage (Part B-ID); Use: Sections 226A,
1836(b) and 1837(n) of the Act provide the statutory authority for this
new, limited Medicare entitlement program. It is stated in Sec.
407.1(a)(6) that, sections 1836(b) and 1837(n) of the Act provide for
coverage of immunosuppressive drugs as described in section
1861(s)(2)(J) of the Act under Part B beginning on or after January 1,
2023, for eligible individuals whose benefits under Medicare Part A and
eligibility to enroll in Part B on the basis of ESRD would otherwise
end with the 36th month after the month in which the individual
receives a kidney transplant by reason of section 226A(b)(2) of the
Act.
The CMS-10798 provides the necessary information to determine
eligibility and to process the beneficiary's request for enrollment for
in Part B-ID coverage. This form is only used for enrollment by
beneficiaries whose Medicare entitlement based on ESRD would otherwise
end after a successful kidney transplant to continue enrollment under
Medicare Part B only for the coverage of immunosuppressive drugs who
already have Part A, but not Part B.
Form CMS-10798 is completed by the individual or is completed by an
SSA representative using information provided by the Medicare enrollee
during a telephone interview. The form is owned by CMS, but not
completed by CMS staff. SSA processes Medicare enrollments on behalf of
CMS. Form Number: CMS-10798 (OMB control number: 0938-1428); Frequency:
Once; Affected Public: Individuals and Households, State, Local, or
Tribal Governments; Number of Respondents: 1,019; Total Annual
Responses: 1,019; Total Annual Hours: 173. (For policy questions
regarding this collection contact Tyrissa Woods at 410-786-0286 or
<a href="/cdn-cgi/l/email-protection#1f4b666d766c6c7e316870707b6c5f7c726c3177776c31787069"><span class="__cf_email__" data-cfemail="44103d362d3737256a332b2b2037042729376a2c2c376a232b32">[email protected]</span></a>.)
William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts,
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-30620 Filed 12-20-24; 8:45 am]
BILLING CODE 4120-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 23, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.